Dr. Rajeev Singh Raghuwanshi Reappointed as Drugs Controller India on Contract Basis
New Delhi: Through a recent notification, the Appointments Committee of the Cabinet has approved the re-employment of Dr. Rajeev Singh Raghuwanshi as the Drugs Controller (India) at the Central Drugs Standard Control Organisation (CDSCO) on a contract basis for a period of one year effective from March 1, 2025, i.e., beyond his attaining the age of superannuation, or till the appointment of a regular incumbent to the post, or until further orders, whichever is the earliest, by keeping the Recruitment Rules of the post in abeyance.
The appointment will be on a contract basis for one year, effective from March 1, 2025.
The notice further added that Dr. Raghuwanshi’s re-employment comes despite his attainment of superannuation, with the contract extending his service until the appointment of a regular incumbent or further orders, whichever is earlier. The government has decided to keep the recruitment rules of the post in abeyance for the time being.
The official communication regarding this appointment was issued by Ramesh Chandra Jha, Under Secretary (EO-SM.II), Department of Personnel and Training, Secretariat of the Appointments Committee of the Cabinet. Copies of the order were also sent to the Prime Minister’s Office, the Cabinet Secretariat, and the Guard File for record purposes.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.